1 Cite Share 501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to bamlanivimab in vitro. Liu H, Wei P, Zhang Q, Chen Z, Aviszus K, Downing W, Peterson S, Reynoso L, Downey GP, Frankel SK, Kappler J, Marrack P, Zhang G. MAbs. 2021 Jan-Dec;13(1):1919285. doi: 10.1080/19420862.2021.1919285. PMID: 34074219 Free PMC article. 2 Cite Share The basis of a more contagious 501Y.V1 variant of SARS-CoV-2. Liu H, Zhang Q, Wei P, Chen Z, Aviszus K, Yang J, Downing W, Jiang C, Liang B, Reynoso L, Downey GP, Frankel SK, Kappler J, Marrack P, Zhang G. Cell Res. 2021 Jun;31(6):720-722. doi: 10.1038/s41422-021-00496-8. Epub 2021 Apr 23. PMID: 33893398 Free PMC article. No abstract available. 3 Cite Share JMJD5 couples with CDK9 to release the paused RNA polymerase II. Liu H, Ramachandran S, Fong N, Phang T, Lee S, Parsa P, Liu X, Harmacek L, Danhorn T, Song T, Oh S, Zhang Q, Chen Z, Zhang Q, Tu TH, Happoldt C, O'Conner B, Janknecht R, Li CY, Marrack P, Kappler J, Leach S, Zhang G. Proc Natl Acad Sci U S A. 2020 Aug 18;117(33):19888-19895. doi: 10.1073/pnas.2005745117. Epub 2020 Aug 3. PMID: 32747552 Free PMC article. 4 Cite Share The potential underlying mechanism of the leukemia caused by MLL-fusion and potential treatments. Liu H, Lee S, Zhang Q, Chen Z, Zhang G. Mol Carcinog. 2020 Jul;59(7):839-851. doi: 10.1002/mc.23204. Epub 2020 Apr 24. PMID: 32329934 Review. 5 Cite Share